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Abstract 
Background: This study aimed to investigate the value of fine needle aspiration biopsy (FNAB) under ultrasound 
guidance in diagnosis of thyroid nodules. In a retrospective analysis of FNAB in 1050 cases of patients with 1100 nod-
ules, patients were divided according to the maximum diameter of their nodules into two groups: >1.0 and ≤1.0 cm. 
The ultrasound-guided FNAB cytology results were compared between two groups.
Results: Ultrasound findings showed that among 1100 thyroid nodules, 547 were highly suspicious, 358 were mod-
erately, 175 were low, and 19 were very low. Cytology results showed papillary carcinomas in 453, possible papillary 
cancer in 126 cases, follicular tumors in 26, suspicious follicular tumors in 6, atypical cells in 7, nodular goiter in 289, 
colloid in 13, chronic lymphocytic thyroiditis in 175, and undiagnosed specimen in 5. Ultrasound diagnosis of thyroid 
nodules had an overall sensitivity of 86.0 %, and a specificity of 81.9 %. In nodules larger than 1.0 cm, the sensitivity 
was 92.8 %, and the specificity 92.3 %. In nodules ≤1.0 cm, the sensitivity was 82.4 %, and the specificity was 81.7 %.
Conclusions: Patients with highly suspicious thyroid nodules on ultrasonography, regardless of nodule sizes, should 
receive ultrasound-guided FNAB to confirm their natures and direct clinical managements.
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Background
With the improved resolution of high frequency ultra-
sound and new technologies, the detection rate of thy-
roid nodules has improved significantly, but it is still 
necessary to use ultrasound-guided fine-needle aspira-
tion biopsy (US-FNAB) to determine the nature of thy-
roid nodules (Singh Ospina et al. 2016; Kaliszewski et al. 
2016). US-FNAB has many advantages, such as real-time 
guidance, simple operation, safe, few contraindications 
and complications, and an effective method to identify 
the benign and malignant thyroid nodules (Cooper et al. 
2009; Moon et  al. 2012; Kim et  al. 2009a, b; Lee et  al. 
2011). This study was a retrospective analysis of 1050 
patients with a total of 1100 thyroid nodules, which were 
divided into two groups of the maximum diameter over 
1.0  cm and less than or equaling to 1.0  cm, Ultrasound 
and cytology were adopted to analyze the value of US-
FNAB in the diagnosis of thyroid nodules.
Methods
Study design
US-FNAB results of patients with thyroid nodules from 
January 2013 to December 2013 were retrospectively 
analyzed. In 2013, there were more than 40,000 patients 
underwent thyroid ultrasound in Department of Ultra-
sound of Ruijin Hospital. Among them, there are 5000 
thyroid patients received US-FNAB, and about 4000 
patients received surgical interventions. Inclusion cri-
teria were as follows: 1. patients receiving thyroid ultra-
sound in our hospital; 2. nodules with cytological results; 
3. nodules suspicions for malignancy confirmed by surgi-
cal pathology; 4. negative cytological nodules confirmed 
by follow-ups for more than 1 year with unchanged ultra-
sound appearances or by surgical pathology (Frates et al. 
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2005). A total of 1050 cases of patients (298 males and 
752 females) with a mean age of 46.0  ±  13.5  years old 
(range 16–84 years old). A total of 1100 thyroid nodules 
were divided into two groups with the maximum diam-
eter over 1.0 cm and the maximum diameter less than or 
equaling to 1.0 cm.
Instruments and methods
A SIEMENS S2000 using color ultrasound scanner with 
an ACUSON-18L6HD UHF probe was adopted and the 
instrument was adjusted to the best image quality. Every 
patient lay in a supine position with a thin pillow under 
the shoulders, and the neck extended. A comprehensive 
thyroid scan was performed to detect any nodule and 
images were stored.
Ultrasound thyroid nodules and classification criteria
The number, location, size, shape, aspect ratio, mar-
gin, ultrasound halo, internal structure, calcifications, 
posterior echo, and the extent and pattern of the blood 
supply of nodules were evaluated. The thyroid nodules 
and differentiated thyroid cancer treatment guidelines 
released by American Thyroid Association (ATA) in 2014 
based on ultrasound characteristics to predict risks of 
malignancy. The guideline considered sonographic fea-
tures of malignant nodules as hypoechoic texture with 
irregular margins (such as surrounding infiltration and 
small projections), microcalcifications, vertical growth, 
and nodular or partial annular calcification. Based on 
these features, thyroid nodules were divided into high, 
moderate, low, and very low degrees of suspicion, and 
benign ones. High suspicion referred to solid hypo-
echoic nodules or a solid hypoechoic nodule with a cystic 
component, and the combination of the following char-
acteristics: irregular edges (such as invasion of the sur-
rounding tissue), microcalcifications, vertical growth, 
nodular or partial annular calcification with destruc-
tion zone, hypoechoic soft tissue protrusion, invasion 
into surrounding thyroid. Moderate suspicion referred 
to hypoechoic solid nodules with smooth margins, no 
microcalcifications, no invasion, and vertical growth. 
Low suspicion referred to hyperechoic nodules or cystic 
nodules, solid areas, uniform texture, no microcalcifi-
cations, regular margins, no extracapsular spread, and 
non-vertical orientation. Very low suspicion referred 
sponge-like nodules or partially cystic nodules, not asso-
ciated with low, medium and high suspicion in any one 
of sonographic features. Benign ones referred to purely 
cystic nodules (Brito et al. 2014; Horvath et al. 2009; Ito 
et al. 2007; Tae et al. 2007).
In this study, images were retrospectively analyzed by 
two double-blinded Sonologists to determine the clas-
sification according to the 2014 ATA guidelines. They 
were classified as high, moderate, low, and very low sus-
picion and benign. If there was disagreement in the clas-
sification, the final classification should be reached by 
consensus.
US‑FNAB material
The materials consisted of 5  ml disposable plastic 
syringes, 27G syringe needles, gloves, iodine swabs, 1 % 
lidocaine, slides, bottles and ethanol fixed fast staining 
solution.
US‑FNAB specimen collection
Preoperative coagulation function and body condi-
tion of all patients were assessed. Informed consent was 
obtained. After routine disinfection, sterile towels were 
applied, and lidocaine was injected for local anesthesia 
to the thyroid capsule under ultrasound guidance. Under 
ultrasound-guidance, specimens were collected by aspi-
rated into 5 ml plastic syringes. Thyroid specimens were 
collected 2–6 times, according to the specific circum-
stances of each case.
Standard thyroid nodule cytology specimens
There was an on site cytologist in the cell room next to 
the ultrasound examination room. By using the “Thyroid 
Cytopathology Bethesda reporting system (Cibas and Ali 
2009): definitions, standards and notes”, the specimens 
were divided into six categories: I: specimen cannot be 
diagnosed or was unsatisfactory, II: benign, III: equivocal 
lesions (atypical cells or follicular lesions), IV: follicular 
neoplasm or suspicious follicular tumors, V: suspicious 
for malignancy, VI: malignancy. According to the 2010 
AACE/AME/ETA “European thyroid nodule diagnosis 
and treatment guidelines”, Bethesda categories I to IV 
were classified as “negative cytology”, while categories V 
and VI were classified as “positive cytology”.
Statistical analysis
In results of US-FNAB cytology, surgical pathology and 
ultrasound follow-up of more than 1  year, data were 
analyzed by using SPSS version 19.0 statistical software. 
t-test was used to compare the cytological categories 
between two groups, and numerical data were compared 
with χ2 test, while consistency of paired data was ana-
lyzed with Kappa test.
Results
In the 1050 patients, a total of 1100 nodules of maximum 
diameters from 0.29 to 2.8 cm with an average diameter 
of 1.08 ±  0.53  cm were found. There were 322 nodules 
larger than 1.0 cm and 778 of 1 cm or smaller (amongst 
which 292 cases were smaller than 0.5  cm). Cytologi-
cal results showed benign in 521 nodules (confirmed by 
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surgery in 23, and by follow-ups for more than 1 year in 
493). Cytological results were malignant in 579 nodules, 
confirmed by surgery. Cytological results were satisfac-
tory in 1095 (99.55 %) cases and non-diagnostic or unsat-
isfactory in 5 (0.45 %), all of which were 0.6 cm or smaller 
and were managed by follow-ups.
Thyroid nodule ultrasound results
The 2014 ATA guidelines recommend dividing thyroid 
nodules into five categories based on ultrasonographic 
features, which were high, moderate, low, very low level 
of suspicion of malignancy, and benign. Results showed 
benign in one nodule (0.1 %); very low level of suspicion 
in 19 nodules (1.7 %); low level of suspicion in 175 nod-
ules (15.9  %); moderate level of suspicion in 358 nod-
ules (32.5 %); and high level of suspicion in 547 nodules 
(49.7  %). Among nodules smaller than 1.0  cm, results 
showed benign in 0 nodules (0 %); very low level of sus-
picion in 8 nodules (1  %); low level of suspicion in 98 
nodules (12.6 %); moderate level of suspicion in 254 nod-
ules (32.6 %); and high level of suspicion in 418 nodules 
(53.7 %). Among those larger than 1.0 cm, results showed 
benign in 1 nodule (0.3  %); very low level of suspicion 
in 11 nodules (3.4  %); low level of suspicion in 77 nod-
ules (23.9  %); moderate level of suspicion in 104 nod-
ules (32.3 %); and high level of suspicion in 129 nodules 
(40.1 %).
US‑FNAB cytology results
The overall US-FNAB cytology results are shown in 
Table 1. US-FNAB cytopathological results of this study, 
and the results according to nodule sizes are shown in 
Table 2.
Ultrasound compared with US‑FNAB cytology results
The relationship between ultrasound features of nod-
ules and US-FNAB cytopathological is presented in 
Table  3. The relationship between ultrasound features 
by nodule sizes and US-FNAB cytology is presented 
in Table  4, while the effects of the patient’s gender and 
cytopathological results are presented in Table 5. In this 
study, the overall sensitivity of ultrasound in diagnosing 
nodules was 86.0  % and the specificity was 81.9  %. The 
sensitivity for larger nodules was 92.8 %, and the specific-
ity was 92.3  %, while for smaller nodules the sensitivity 
was 82.4 %, and the specificity was 81.7 %.  
Discussion
Thyroid nodules are common abnormalities of the endo-
crine system. Although the incidence in different regions 
of the world is different, the overall upward trend is 
strong (Xu et  al. 2015). With the use of high-resolution 
ultrasound and the introduction of new technologies, 
Table 1 Bethesda cytology of thyroid nodules








Table 2 US-FNAB cytology pathology Bethesda results 
by nodule size
χ2 = 15.900, p = 0.007
Nodule size I II III IV V VI Total
Maximum diameter ≤1.0 cm 3 311 6 20 95 343 778
Maximum diameter >1.0 cm 2 166 1 12 31 110 322
Total 5 477 7 32 126 453 1100
Table 3 Ultrasound findings vs US-FNAB cytology Results
Ultrasound Negative Positive Total
Benign 1 0 1
Very low suspicion 18 1 19
Low suspicion 133 42 175
Moderate suspicion 296 62 358
High suspicion 73 474 547
Total 521 579 1100







Very low suspicion 7 1
Low suspicion 69 29
Moderate suspicion 204 50





Very low suspicion 11 0
Low suspicion 64 13
Moderate suspicion 92 12
High suspicion 13 116
Total 181 141
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such as elastography, ultrasound has become the first 
choice for the diagnosis of thyroid nodules (Burch et al. 
2016). As shown in a national large-scale study, ultra-
sound examination of the thyroid revealed nodules in 
20–76  % (Gharib et  al. 2010), which was a dramatic 
increase over the last 10 years. With a prevalence rate of 
5–15 % (Cooper et al. 2009), thyroid cancer has become 
a common clinical malignancy with an increasing inci-
dence all over the world (Londero et al. 2013; Davies and 
Welch 2006). The rate of unnecessary thyroid surgery has 
also increased. US-FNAB is a non-invasive way to dis-
criminate benign thyroid nodules from malignant ones, 
and can reduce unnecessary diagnostic surgeries.
The 2014 ATA guideline (Horvath et al. 2009; Ito et al. 
2007; Tae et  al. 2007), relies on sonographic features to 
predict risks of malignant thyroid nodules, divides them 
into high, moderate, low, and very low degree of suspi-
cion, and gives the corresponding probability of malig-
nancy. The risk of malignancy in 70–90  % in a thyroid 
nodule was rated as high suspicion, a risk of malignancy 
in 10–20  % was rated as moderate suspicion, a risk of 
malignancy in 5–10 % was rated as low suspicion, a risk 
of malignancy in <3  % was rated as very low suspicion, 
and a risk of malignancy in <1 % was rated as benign nod-
ules. Results of this study showed that in nodules rated as 
“high” and “moderate” suspicion, the proportion of thy-
roid nodules with positive cytological results was similar 
to the 2014 ATA guidelines. For nodules with “low”, and 
“very low” degrees of suspicion, the rate of positive US-
FNAB cytological results was significantly higher than 
that in the guidelines. Management of thyroid nodules 
depends on the level of suspicion. For nodules with high 
and moderate suspicion, US-FNAB is recommended, 
while follow-up is generally recommended for nod-
ules with low degree of suspicion and US-FNAB is not 
needed unless there is a family history of thyroid cancer, 
exposure to ionizing radiation or a strong biopsy request 
from patients. When the level of suspicion is very low, 
US-FNABs is not needed.
The 2014 ATA guideline stated that US-FNAB was 
the most reliable method for preliminary diagnosis of 
thyroid nodules (Cooper et  al. 2009). Many literatures 
(Nayar and Ivanovic 2009; Bongiovanni et  al. 2012; Luu 
et  al. 2011; Theoharis et  al. 2009) described patients in 
whom US-FNAB was done in 89–95 % of cases, including 
55–74 % cases diagnosed as benign, 2–5 % diagnosed as 
malignant, and the remaining diagnosed as “indetermi-
nate cytology”. The nodules with unsatisfactory biopsies 
(Moon et al. 2012; Horvath et al. 2009; Chen et al. 2009) 
mainly include cystic nodules, calcified nodules, nodules 
with a rich blood supply, and tough nodules difficult to 
be punctured. Nodules smaller than 6  mm and benign 
nodules are likely to yield insufficient amount of cells. 
The question of how to deal with cases when the cytology 
is not clear is an active area of research. For cases with 
indeterminate cytological results, ATA guidelines recom-
mended a repeat biopsy. From the literature of Cooper, 
a repeat biopsy can confirm the diagnosis in about 75 % 
of solid nodules (Cooper et al. 2009). In this study, it was 
able to obtain satisfactory specimens in 99.55  % cases, 
which was higher than that reported in the literature. In 
addition to operator’s experience, it was suggested that it 
was not easy to obtain a satisfactory specimen if less than 
six punctures were made (Kim et al. 2009a).
The relevance of nodule size to the results of US-FNAB 
has been controversial. The 2006 ATA guidelines recom-
mended US-FNAB for nodules with diameters larger 
than 1.0 cm, the 2009 edition reduced the size of suspi-
cious nodules to a diameter larger than 0.5 cm, and the 
2014 edition was skeptical about the value of biopsy for 
nodules with diameters less than 1.0 cm. Recommenda-
tions for US-FNAB of nodules with diameters larger than 
1.0  cm should be based on the following criteria: find-
ings outside the thyroid such as invasion or lymph node 
metastasis, the patient’s age, and the demands of process 
(Frates et al. 2005; Mazzaferri and Sipos 2008). However, 
some scholars (Kim et  al. 2009a, b; Baskin and Duick 
2006) believed that early diagnosis of thyroid cancer 
could reduce the recurrence rate and mortality regardless 
of nodule sizes. Long-term follow-up of small biopsy-
proven papillary thyroid cancers did not show distant 
metastases or mortality (Mazzaferri and Sipos 2008), but 
young patients (younger than 40 years old) were prone to 
clinical progression, including rapid tumor growth and 
cervical lymph node metastases. From the histological 
point of view, the literatures (Nikiforov and Ohori 2012; 
Ghossein et al. 2007; Morris et al. 2010) on papillary thy-
roid carcinoma listed a dozen subtypes, some of which 
carried a poor prognosis with a high recurrence rate, 




Pathological diagnosis Male Female
Maximum diameter ≤1.0 cma Benign 81 259
Malignant 128 310
Total 209 569
Maximum diameter >1.0 cmb Benign 47 134
Malignant 50 91
Total 97 225
Totalsc Benign 128 393
Malignant 178 401
Total 306 794
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and a low tumor-related survival rate. In these cases, the 
patient’s age, tumor size and clinical staging were irrele-
vant. Therefore, regardless of the size of thyroid nodules, 
clarifying their nature to guide clinical management still 
has a great value.
In this study, the results of US-FNAB cytology of thy-
roid nodules with diameters of 1.0  cm or smaller was 
similar to those larger than 1.0  cm. However, in 182 
patients younger than 40  years old with highly suspi-
cious thyroid nodules, US-FNAB cytology was positive 
in 179 (98.4 %). Thus, for highly suspicious thyroid nod-
ules, especially in patients younger than 40  years old, 
timely US-FNAB is clinically significant for confirma-
tion of their natures.
However, this study had some limitations. This study 
was a retrospective study. The majority of patients with 
benign cytology were followed up, since thyroid cancer 
develops slowly. A relatively short follow-up of 1 year did 
not exclude false negative results. Two cases with positive 
preoperative US-FNAB but negative histology in very 
small nodules were excluded.
Conclusions
Highly suspicious thyroid nodules on ultrasonography, 
regardless of nodule sizes, should receive US-FNAB to 
confirm their natures and direct clinical managements.
Abbreviation
US-FNAB: ultrasound-guided fine-needle aspiration biopsy.
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